1 that 'the data acquired from pulse wave analysis and simultaneous measurement of brachial arterial BP by conventional sphygmomanometry can be utilised to derive values for central aortic systolic and diastolic BPs using a validated mathematical transfer function'. They also state 1 that '% the central aortic wave form and pressure indices (the maximum and minimum pressures of the central waveform in mm Hg) are derived from radial tonometry and the peripheral brachial BP using a previously validated mathematical transfer function within the software package (Sphygmocor ™ This is important because when researchers have tested GTFs with non-invasive calibration, substantial errors have been observed. In one study of 20 patients, a mean difference of +11 mm Hg was observed between measured and estimated aortic systolic BP, with a mean difference of −8 mm Hg between measured and estimated aortic diastolic BP. 2 In a second study of 19 patients (using a different GTF), errors Ͼ10 mm Hg in 67% of cases were recorded, leading to the non-invasive calibration being scrapped. 3 According to the Association for the Advancement of Medical Instrumentation, in guidelines endorsed by the US Food and Drug Administration, when the accuracy of any new BP measurement method is compared with that of an intra-arterial catheter the maximal mean allowable difference both for systolic and diastolic BPs is 5 mm Hg. 4 Therefore far from the Sphygmocor being 'validated' 1 it appears that it does not actually comply with these guidelines.
Nevertheless some researchers have just started to report their use of the technique, on the assumption that the values obtained yield central aortic BPs and indices. However close inspection of the papers being cited reveals, repeatedly, that the references do not actually support the claims which are being made of them. 5 In this respect, while Siebenhofer et al 1 have tried to concentrate on reproducibility, a non-invasive measurement can be quite reproducible without necessarily being at all accurate. 6 For this reason the accuracy of a new BP measurement technique should be evaluated, and reported, before proceeding onto reproducibility and clinical outcome studies.
For a validation study to be valid it clearly must test the system in an identical manner to that which is being applied in practice. 5 This is not happening for the literature being cited as having 'validated' the Sphygmocor system. Indeed a search on Medline up to June 2000 -using 'sphygmocardiography', 'Sphygmocor', and 'pulse wave analysis' as search termsrevealed an absolute paucity of validation data.
Before patients are subjected to 'multicentre clinical trials' 1 using the Sphygmocor -and long-term 'prospective studies' 1 to determine cardiovascular outcome -the apparatus needs to be taken into a cardiac catheter laboratory and its accuracy in estimating central aortic BP needs to be properly
